Matthew was a CCB Fellow in 2017 working in the Section on Human Psychopharmacology at the National Institute on Alcohol Abuse and Alcoholism (NIAAA). His research employed novel human laboratory approaches to investigate how vulnerability for alcohol use disorder predicts alcohol consumption patterns in young adults. He also studied the relationship between endocannabinoid signaling and substance use by leveraging large databases.
Matthew completed medical school and psychiatry residency at McGill University in Montreal, Quebec and continues to maintain an active clinical practice in Montreal, which primarily focuses on treating individuals with dual diagnoses. He is currently doing an Addiction Psychiatry Fellowship at Yale School of Medicine, and remains at NIAAA as a Special Volunteer and Guest Researcher where he will continue to work on the research he undertook as a CCB Fellow.